DP-R212

DRUG2 trials

Sponsors

Alvogen Korea

Conditions

HealthyHypercholesterolemiaHypertension

Phase 1

DP-R212 Pharmacokinetic Study Phase I

Alvogen KoreaHealthy

Start: 2016-07-31End: 2016-09-30Target: 36Updated: 2016-06-27

Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

WithdrawnNCT02955368

Alvogen KoreaHypercholesterolemia, Hypertension

Start: 2017-02-28End: 2017-08-31Updated: 2017-06-05